dr. vokes on pembrolizumab plus chemotherapy and radiation in lung cancer
Published 7 years ago • 325 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
0:40
dr. vokes on selecting nivolumab or pembrolizumab for head and neck cancer treatment
-
1:40
dr. vokes discusses the administration of multimodality therapy for lung cancer
-
2:53
keynote-407: pembrolizumab plus chemo improves os and pfs in nsclc
-
1:16
dr. vokes on parp inhibitors for nsclc
-
1:14
dr. minna on chemotherapy and radiation therapy for lung cancer
-
3:22
dr. vokes discusses parp inhibitors in lung cancer
-
2:07
dr. vokes on the standard of care for stage iii nsclc
-
2:15
dr. ramalingam on pembrolizumab and chemotherapy in nsclc
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
3:44
pembrolizumab plus chemo shows prolonged os and pfs improvement vs chemo for squamous nsclc
-
0:57
dr. vokes on moving immunotherapy into frontline for head and neck cancer
-
1:53
dr. spigel on pembrolizumab/chemo combo in first-line nsclc
-
7:13
first-line pembrolizumab plus chemotherapy for patients with advanced squamous nsclc: 3-year fol...
-
4:23
keynote-407: 3-year follow-up of pembrolizumab plus chemo in nsclc
-
3:37
pembrolizumab plus chemo as firstline therapy for nsclc
-
1:15
dr. spigel on fda approval of pembrolizumab/chemo combo in nsclc
-
1:53
#pembrolizumab (keytruda) plus #chemotherapy in metastatic non-small cell #lungcancer (nsclc)
-
1:59
dr. vokes discusses parp inhibitors in lung cancer
-
1:48
dr. brahmer discusses frontline single-agent pembrolizumab in lung cancer